ASM Journal Press Releases

Clinical and Vaccine Immunology (CVI) enhances understanding of the immune response in health and disease and after vaccination by showcasing discoveries in clinical, laboratory, and vaccine immunology.

Areas of focus include cellular and humoral immunity in humans and animals, immunological and immune-mediated disorders, immunotherapy, microbial immunology and microbial immune pathogenesis, veterinary and One Health immunology, development and standardization of immunological assays, and immunoepidemiology.

CVI is also committed to advancing all aspects of vaccine research and immunization, including discovery of new vaccine antigens and vaccine design, development and evaluation of vaccines in animal models and in humans, characterization of immune responses and mechanisms of vaccine action, controlled challenge studies to assess vaccine efficacy, study of vaccine vectors, adjuvants, and immunomodulators, immune correlates of protection, and clinical trials.

View original post here:
Clinical and Vaccine Immunology